Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro

Glyn D Palmer1, Andre Steinert, Arnulf Pascher

  • 1Center for Molecular Orthopaedics, Harvard Medical School, Boston, MA 02115, USA.

Insights

Gene transfer of TGF-beta1 and BMP-2 effectively induced chondrogenesis in mesenchymal stem cells (MSCs). Optimal results were achieved with moderate protein levels, while high levels or viral loads inhibited the process.

Area of Science:

  • Regenerative Medicine
  • Molecular Biology
  • Biotechnology

Background:

  • Adult mesenchymal stem cells (MSCs) can differentiate into cartilage and bone.
  • The role of gene transfer in inducing MSC chondrogenesis is not well understood.

Purpose of the Study:

  • To investigate chondrogenesis of MSCs using adenoviral gene transfer of growth factors.
  • To determine the impact of growth factor expression levels and duration on chondrogenesis.

Main Methods:

  • Primary bone marrow-derived MSCs were cultured in aggregates.
  • MSCs were genetically modified using adenoviral vectors encoding TGF-beta1, BMP-2, or IGF-1.
  • Chondrogenesis was assessed via toluidine blue staining and type II collagen detection.

Main Results:

  • Adenoviral expression of TGF-beta1 and BMP-2 induced MSC chondrogenesis.
  • Chondrogenesis correlated with protein expression levels (10-100 ng/ml) and duration.
  • High expression levels (>100 ng/ml) and high adenoviral loads inhibited chondrogenesis.

Conclusions:

  • Gene transfer of specific growth factors can induce MSC chondrogenesis.
  • Expression levels, duration, and viral load are critical parameters for successful gene therapy-guided chondrogenesis.
  • These findings are important for developing gene transfer strategies for cartilage regeneration.